Financial results - ALFAMED S.R.L.

Financial Summary - Alfamed S.r.l.
Unique identification code: 13359465
Registration number: J20/477/2000
Nace: 8622
Sales - Ron
163.815
Net Profit - Ron
62.992
Employee
16
The most important financial indicators for the company Alfamed S.r.l. - Unique Identification Number 13359465: sales in 2023 was 163.815 euro, registering a net profit of 62.992 euro and having an average number of 16 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Alfamed S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 99.219 98.803 96.183 134.763 129.827 134.808 104.614 107.892 169.403 163.815
Total Income - EUR 99.240 99.300 96.561 134.783 129.829 134.810 106.396 107.892 169.403 163.821
Total Expenses - EUR 57.136 57.045 53.548 57.721 57.624 68.464 48.243 55.866 110.230 99.191
Gross Profit/Loss - EUR 42.104 42.256 43.013 77.061 72.205 66.346 58.153 52.026 59.173 64.631
Net Profit/Loss - EUR 35.364 35.495 36.131 75.774 70.907 64.997 57.089 50.947 57.142 62.992
Employees 14 13 13 11 12 1 1 15 16 16
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -3.0%, from 169.403 euro in the year 2022, to 163.815 euro in 2023. The Net Profit increased by 6.024 euro, from 57.142 euro in 2022, to 62.992 in the last year.

Check the financial reports for the company - Alfamed S.r.l.

Rating financiar

Financial Rating -
Alfamed S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Alfamed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Alfamed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Alfamed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Alfamed S.r.l. - CUI 13359465

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 122.834 126.113 120.780 127.352 120.452 112.289 105.444 99.904 95.980 93.027
Current Assets 76.656 75.289 77.977 10.373 11.461 75.321 75.008 70.481 76.525 89.245
Inventories 0 0 0 0 1.330 0 0 37.271 0 0
Receivables 8.896 6.687 7.531 9.426 9.621 8.630 25.143 4.594 3.912 14.927
Cash 67.760 68.602 70.446 947 509 66.691 49.865 28.617 72.613 74.318
Shareholders Funds 196.121 197.593 196.586 128.997 123.153 116.233 171.118 162.448 169.054 174.566
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 3.756 4.198 2.284 8.883 8.760 71.378 9.333 7.937 3.451 7.706
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 89.245 euro in 2023 which includes Inventories of 0 euro, Receivables of 14.927 euro and cash availability of 74.318 euro.
The company's Equity was valued at 174.566 euro, while total Liabilities amounted to 7.706 euro. Equity increased by 6.024 euro, from 169.054 euro in 2022, to 174.566 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Alfamed S.r.l.

Comments - Alfamed S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.